AML-derived Extracellular Vesicles Confer De Novo Chemoresistance to Leukemic Myeloblast Cells by Promoting Drug Export Genes Expression and ROS Inhibition

In spite of successful initial remission, chemo-resistance and relapse are still concerning points in acute myeloid leukemia (AML) treatment strategies. Multidrug resistance (MDR) appears to be the major contributor of chemo-resistance, arising in some sub-clones of cancers and could be developed in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Iran J Pharm Res
Autors principals: Barzegar, Mohieddin, Allahbakhshian Farsan, Mehdi, Amiri, Vahid, Mohammadi, Saeed, Shahsavan, Shaghayegh, Mirzaeian, Amin, Mohammadi, Mohammad Hossein
Format: Artigo
Idioma:Inglês
Publicat: Shaheed Beheshti University of Medical Sciences 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8170774/
https://ncbi.nlm.nih.gov/pubmed/34400967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22037/ijpr.2020.113272.14199
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars